This Weekend my eyes and thoughts curved around the Healthcare sector. I read several interesting articles from the sector, mostly about the biotech’s …
The stock market isn’t providing good discounts especially in quality names, but at least the return of volatility is providing some opportunities for …
Biotechnology has been an extremely hot industry thanks to high demand for the sector and new drugs which are boosting revenues across the …
On January 5th, biopharmaceutical company Amgen Inc. (NASDAQ: AMGN) announced plans to collaborate with Kite Pharma (NASDAQ: KITE) on cancer treatments.
In a research report released yesterday, William Blair analyst John Sonnier reaffirmed a Market Perform rating on Amgen Inc. (AMGN) on the heels …